SPG21 Protein, Human, Recombinant (GST) is expressed in Baculovirus insect cells with GST tag. The predicted molecular weight is 61 kDa and the accession number is Q9NZD8-1.
説明 | SPG21 Protein, Human, Recombinant (GST) is expressed in Baculovirus insect cells with GST tag. The predicted molecular weight is 61 kDa and the accession number is Q9NZD8-1. |
Species | Human |
Expression Host | Baculovirus Insect Cells |
Tag | N-GST |
Accession Number | Q9NZD8-1 |
別名 | ACP33, GL010, spastic paraplegia 21 (autosomal recessive, Mast syndrome), BM-019, MAST |
Construction | The full length of Human SPG21 (NP_057714.1) (Met 1-Gln 308) |
Protein Purity | > 90 % as determined by SDS-PAGE |
分子量 | 61 kDa (predicted) |
Endotoxin | < 1.0 EU/μg of the protein as determined by the LAL method. |
Formulation | Lyophilized from a solution filtered through a 0.22 μm filter, containing 50 mM Tris, 100 mM NaCl, pH 8.0, 10% glycerol. Typically, a mixture containing 5% to 8% trehalose, mannitol, and 0.01% Tween 80 is incorporated as a protective agent before lyophilization. |
Reconstitution | A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information. |
Stability & Storage |
It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at-80℃. For reconstituted proteinsolutions, the solution can be stored at -20°c to -80'c for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
Shipping |
In general, Lyophilized powders are shipping with blue ice. |
Research Background | Spastic paraplegia 21 (SPG21), also known as acid Cluster Protein 33 (ACP33) and Mast syndrome protein, is a member of the AB hydrolase superfamily. Human SPG21 is a 38 amino acid residue protein widely expressed in all tissues, including heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. SPG21 binds to the hydrophobic C-terminal amino acids of CD4 which are involved in repression of T cell activation via the noncatalytic alpha/beta hydrolase fold domain. SPG21 thus is proposed to play a role as a negative regulatory factor in CD4-dependent T-cell activation of CD4. Defects in SPG21 are the cause of spastic paraplegia autosomal recessive type 21, also known as Mast syndrome, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. SPG21 is also associated with dementia and other central nervous system abnormalities. |
bottom
Please read the User Guide of Recombinant Proteins for more specific information.
SPG21 Protein, Human, Recombinant (GST) autosomal recessive, Mast syndrome GL 010 ACP 33 ACP33 GL-010 GL010 spastic paraplegia 21 (autosomal recessive, Mast syndrome) BM-019 BM 019 BM019 MAST spastic paraplegia 21 ACP-33 recombinant recombinant-proteins proteins protein